申请人:Nippon Chemiphar Co., Ltd.
公开号:US05091403A1
公开(公告)日:1992-02-25
Disclosed are novel imidazole derivatives having the formula: ##STR1## wherein R.sup.1 is hydrogen or an alkyl group having 1-6 carbon atoms, R.sup.2 is an alkyl group having 2-6 carbon atoms substituted with an alkoxy group having 1-4 carbon atoms, each of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 independently is hydrogen, a halogen, an alkyl group having 1-6 carbon atoms, an alkoxy group having 1-6 carbon atoms, a fluorine-substituted alkyl group having 1-6 carbon atoms, or a fluorine-substituted alkoxy group having 1-6 carbon atoms. The new imidazole derivatives are effective particularly as anti-ulcer agents.
揭示了具有以下结构式的新型咪唑衍生物:其中R.sup.1为氢或具有1-6个碳原子的烷基基团,R.sup.2为具有2-6个碳原子的烷基基团,其上取代有具有1-4个碳原子的烷氧基团,R.sup.3、R.sup.4、R.sup.5和R.sup.6中的每一个独立地为氢、卤素、具有1-6个碳原子的烷基基团、具有1-6个碳原子的烷氧基团、具有1-6个碳原子的氟取代烷基基团或具有1-6个碳原子的氟取代烷氧基团。这些新的咪唑衍生物特别有效作为抗溃疡药物。